Home Tags Transpo-mAb Display

Tag: Transpo-mAb Display

Exelixis and BioInvent Establish Exclusive Option and License Agreement to Develop...

Exelixis and Swedish BioInvent International have entered into an option and license agreement focused on the identification and development of novel antibodies for use...
Featured Image: Laboratory Glass works. Courtesy: © 2010 - 2018. Fotolia Used with permission.

Steffen Heeger, MD, Ph.D to Lead NBE-Therapeutics’ Clinical iADC Development

Privately-owned Swiss, Basel-based, NBE-Therapeutics has appointed Steffen Heeger MD, Ph.D. as Chief Medical Officer to lead the clinical development of NBE-002, the company's first...

X